Epworth Center for Bariatric Surgery, Australia
Bariatric surgery, Obesity surgery

Endoscopic Barrier Therapy

Endoscopic Barrier Therapy involves the insertion of an Endoluminal Sleeve Device which is placed via the mouth and is relatively non-invasive compared to other Bariatric procedures, such as Laparoscopic Gastric Band, Sleeve Gastrectomy or Roux-en-Y Gastric Bypass.

Endoscopic Barrier Therapy is a non-surgical way to bypass a portion of your intestine. By forming a barrier between the food you eat and this section of your intestinal wall, you may experience reduced appetite and greater control of blood sugar levels. The outcome is a reduction in blood sugar levels and excess weight, which may lead to a reduction in diabetes-related complications. Other benefits may also occur including reduction in your cholesterol and blood pressure.

Endoscopic Barrier Therapy has had good results with some clinical trials describing up to 85% remission in Type 2 diabetes together with up to 40% excess weight loss in the patients which they studied

At the present time there is no Medicare rebate for Endoscopic Barrier Therapy and the cost of theEndoluminal Sleeve Device used in the procedure isnot covered by private health insurance.

Not all patients are suitable for Endoscopic Barrier Therapy and the results may vary dependent on your particular circumstances and existing medical conditions.

The group of patients suitable for the Endoscopic Barrier Therapy are those who are aged between 20-70 years and have had no previous gastric or stomach operations, stapling or bypass procedures. Also, patients who are required to take medications such as anticoagulants (blood thinning medicines) may not be suitable for this therapy.

It is suitable for people with Type 2 diabetes and has better results with those whose diabetes has been diagnosed more recently.

While this therapy is generally less invasive than surgery, as with any medical procedure, patients may experience complications or adverse events through the course of the therapy. The most commonly reported effects are mild pain and nausea for several days after the initial placement of the device, which can be managed with medication. Your medical practitioner will provide you with full details on the other potential complications of this type of procedure.

In order to proceed with this procedure you would require an initial consultation and would need to have a referral from your local general practitioner.

Endoscopic Barrier Therapy is designed to be temporary and fully reversible leaving no permanent changes to the body. The Endoluminal Sleeve device is inserted and removed after 12 months. Endoscopic Barrier Therapy has been shown to have beneficial effects both on diabetes and on weight after removal of the device, for up to nine months in some clinical studies that have taken place.



Obesity
Body Mass Index BMI
LAP BAND Surgery
Bilio Pancreatic Diversion BPD
Gastric Bypass
Sleeve Gastrectomy
Contact us
Educational Seminars
Am I a Candidate?
Endoscopic Barrier Therapy
Weight (Kg) : 
Height (cm) : 
The BMI is : 
  © Epworth Centre for Bariatric Surgery- Melbourne, Australia
 Home |Obesity Surgery | Tube Gastrectomy | Feedback | Disclaimer | Privacy | Tell a friend | Sitemap | Contact us